207 related articles for article (PubMed ID: 28303172)
1. Astragaloside IV for Experimental Focal Cerebral Ischemia: Preclinical Evidence and Possible Mechanisms.
Wang HL; Zhou QH; Xu MB; Zhou XL; Zheng GQ
Oxid Med Cell Longev; 2017; 2017():8424326. PubMed ID: 28303172
[TBL] [Abstract][Full Text] [Related]
2. Changes of peripheral-type benzodiazepine receptors in the penumbra area after cerebral ischemia-reperfusion injury and effects of astragaloside IV on rats.
Cao YL; Chen CF; Wang AW; Feng YB; Cheng HX; Zhang WW; Xin W
Genet Mol Res; 2015 Jan; 14(1):277-85. PubMed ID: 25729960
[TBL] [Abstract][Full Text] [Related]
3. Astragaloside IV protects against ischemic brain injury in a murine model of transient focal ischemia.
Luo Y; Qin Z; Hong Z; Zhang X; Ding D; Fu JH; Zhang WD; Chen J
Neurosci Lett; 2004 Jun; 363(3):218-23. PubMed ID: 15182947
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotection of Catalpol for Experimental Acute Focal Ischemic Stroke: Preclinical Evidence and Possible Mechanisms of Antioxidation, Anti-Inflammation, and Antiapoptosis.
Zheng XW; Yang WT; Chen S; Xu QQ; Shan CS; Zheng GQ; Ruan JC
Oxid Med Cell Longev; 2017; 2017():5058609. PubMed ID: 28785376
[TBL] [Abstract][Full Text] [Related]
5. Synergistic protective effect of astragaloside IV-tetramethylpyrazine against cerebral ischemic-reperfusion injury induced by transient focal ischemia.
Yang J; Li J; Lu J; Zhang Y; Zhu Z; Wan H
J Ethnopharmacol; 2012 Mar; 140(1):64-72. PubMed ID: 22207211
[TBL] [Abstract][Full Text] [Related]
6. Antihypertension effect of astragaloside IV during cerebral ischemia reperfusion in rats.
Shen F; Meng Y; He Y; Huang B; Huang J; Wang L
Mol Med Rep; 2023 Jan; 27(1):. PubMed ID: 36331022
[TBL] [Abstract][Full Text] [Related]
7. Astragaloside IV attenuates cerebral ischemia-reperfusion-induced increase in permeability of the blood-brain barrier in rats.
Qu YZ; Li M; Zhao YL; Zhao ZW; Wei XY; Liu JP; Gao L; Gao GD
Eur J Pharmacol; 2009 Mar; 606(1-3):137-41. PubMed ID: 19374856
[TBL] [Abstract][Full Text] [Related]
8. Astragaloside IV reduces cerebral edema post-ischemia/reperfusion correlating the suppression of MMP-9 and AQP4.
Li M; Ma RN; Li LH; Qu YZ; Gao GD
Eur J Pharmacol; 2013 Sep; 715(1-3):189-95. PubMed ID: 23747593
[TBL] [Abstract][Full Text] [Related]
9. Astragaloside IV protects against focal cerebral ischemia/reperfusion injury correlating to suppression of neutrophils adhesion-related molecules.
Li M; Qu YZ; Zhao ZW; Wu SX; Liu YY; Wei XY; Gao L; Gao GD
Neurochem Int; 2012 Apr; 60(5):458-65. PubMed ID: 22342823
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective effects of bacopaside I in ischemic brain injury.
Liu X; Yue R; Zhang J; Shan L; Wang R; Zhang W
Restor Neurol Neurosci; 2013; 31(2):109-23. PubMed ID: 23160060
[TBL] [Abstract][Full Text] [Related]
11. Astragaloside IV from Astragalus membranaceus shows cardioprotection during myocardial ischemia in vivo and in vitro.
Zhang WD; Chen H; Zhang C; Liu RH; Li HL; Chen HZ
Planta Med; 2006 Jan; 72(1):4-8. PubMed ID: 16450288
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of astragaloside on focal cerebral ischemia/reperfusion injury in rats.
Yin YY; Li WP; Gong HL; Zhu FF; Li WZ; Wu GC
Am J Chin Med; 2010; 38(3):517-27. PubMed ID: 20503469
[TBL] [Abstract][Full Text] [Related]
13. Borneol for Regulating the Permeability of the Blood-Brain Barrier in Experimental Ischemic Stroke: Preclinical Evidence and Possible Mechanism.
Chen ZX; Xu QQ; Shan CS; Shi YH; Wang Y; Chang RC; Zheng GQ
Oxid Med Cell Longev; 2019; 2019():2936737. PubMed ID: 30863478
[TBL] [Abstract][Full Text] [Related]
14. Effects of the Combination of the Main Active Components of Astragalus and Panax notoginseng on Inflammation and Apoptosis of Nerve Cell after Cerebral Ischemia-Reperfusion.
Huang XP; Ding H; Lu JD; Tang YH; Deng BX; Deng CQ
Am J Chin Med; 2015; 43(7):1419-38. PubMed ID: 26477799
[TBL] [Abstract][Full Text] [Related]
15. Chuanxiongzine-astragaloside IV decreases IL-1β and Caspase-3 gene expressions in rat brain damaged by cerebral ischemia/reperfusion: a study of real-time quantitative PCR assay.
Zhu ZH; Wan HT; Li JH
Sheng Li Xue Bao; 2011 Jun; 63(3):272-80. PubMed ID: 21681347
[TBL] [Abstract][Full Text] [Related]
16. Astragaloside IV Supplementation Promotes A Neuroprotective Effect in Experimental Models of Neurological Disorders: A Systematic Review.
Costa IM; Lima FOV; Fernandes LCB; Norrara B; Neta FI; Alves RD; Cavalcanti JRLP; Lucena EES; Cavalcante JS; Rego ACM; Filho IA; Queiroz DB; Freire MAM; Guzen FP
Curr Neuropharmacol; 2019; 17(7):648-665. PubMed ID: 30207235
[TBL] [Abstract][Full Text] [Related]
17. A Preclinical Systematic Review and Meta-Analysis of Astragaloside IV for Myocardial Ischemia/Reperfusion Injury.
Zheng Q; Zhu JZ; Bao XY; Zhu PC; Tong Q; Huang YY; Zhang QH; Zhang KJ; Zheng GQ; Wang Y
Front Physiol; 2018; 9():795. PubMed ID: 30018562
[TBL] [Abstract][Full Text] [Related]
18. Ginsenoside Rg1 provides neuroprotection against blood brain barrier disruption and neurological injury in a rat model of cerebral ischemia/reperfusion through downregulation of aquaporin 4 expression.
Zhou Y; Li HQ; Lu L; Fu DL; Liu AJ; Li JH; Zheng GQ
Phytomedicine; 2014 Jun; 21(7):998-1003. PubMed ID: 24462216
[TBL] [Abstract][Full Text] [Related]
19. Co-ultramicronized Palmitoylethanolamide/Luteolin in the Treatment of Cerebral Ischemia: from Rodent to Man.
Caltagirone C; Cisari C; Schievano C; Di Paola R; Cordaro M; Bruschetta G; Esposito E; Cuzzocrea S;
Transl Stroke Res; 2016 Feb; 7(1):54-69. PubMed ID: 26706245
[TBL] [Abstract][Full Text] [Related]
20. The novel VEGF receptor antagonist, VGA1155, reduces edema, decreases infarct and improves neurological function after stroke in rats.
Koyama J; Miyake S; Sasayama T; Chiba Y; Kondoh T; Kohmura E
Kobe J Med Sci; 2010 Aug; 56(1):E1-11. PubMed ID: 21063140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
